首页|疏肝清脂方加减对2型糖尿病合并脂代谢异常患者的临床疗效

疏肝清脂方加减对2型糖尿病合并脂代谢异常患者的临床疗效

扫码查看
目的 考察疏肝清脂方加减对 2 型糖尿病合并脂代谢异常患者的临床疗效.方法 160 例患者随机分为对照组和观察组,每组 80 例,对照组给予常规治疗,观察组在对照组基础上加用疏肝清脂方加减,疗程 8 周.检测临床疗效、脂代谢指标(TC、TG、LDL-C、HDL-C、Chemerin、ApoA1、ApoB、LPa)、糖代谢指标(FBG、2 hPG、HbA1c)、鸢尾素、摄食抑制因子-1、中医证候评分、不良反应发生率变化.结果 观察组总有效率高于对照组(P<0.05).治疗后,2 组HDL-C、鸢尾素升高(P<0.05),TC、TG、LDL-C、Chemerin、ApoA1、ApoB、LPa、糖代谢指标、摄食抑制因子-1、中医证候评分降低(P<0.05),以观察组更明显(P<0.05).2 组不良反应发生率比较,差异无统计学意义(P>0.05).结论 疏肝清脂方加减可安全有效地调节 2 型糖尿病合并脂代谢异常患者糖脂代谢及鸢尾素、摄食抑制因子-1、Chemerin水平.
Clinical effects of Modified Shugan Qingzhi Decoction on patients with type 2 diabetes mellitus complicated with dyslipidemia
AIM To investigate the clinical effects of Modified Shugan Qingzhi Decoction on patients with type 2 diabetes mellitus complicated with dyslipidemia.METHODS One hundred and sixty patients were randomly assigned into control group(80 cases)for 8-week intervention of conventional treatment,and observation group(80 cases)for 8-week intervention of both Shugan Qingzhi Decoction and conventional treatment.The changes in clinical effects,lipid metabolism indices(TC,TG,LDL-C,HDL-C,Chemerin,ApoA1,ApoB,LPa),glucose metabolism indices(FBG,2 hPG,HbA1c),irisin,food ingestion inhibitor-1,TCM syndrome scores and incidence of adverse reactions were detected.RESULTS The observation group demonstrated higher total effective rate than the control group(P<0.05).After the treatment,the two groups displayed increased HDL-C,irisin(P<0.05),and decreased TC,TG,LDL-C,Chemerin,ApoA1,ApoB,LPa,glucose metabolism indices,food ingestion inhibitor-1,TCM syndrome scores(P<0.05),especially for the observation group(P<0.05).No significant difference in incidence of adverse reactions was found between the two groups(P>0.05).CONCLUSION For the patients with type 2 diabetes mellitus complicated with dyslipidemia,Modified Shugan Qingzhi Decoction can safely and effectively regulate glucose and lipid metabolism and levels of irisin,feeding inhibition factor-1,Chemerin.

Shugan Qingzhi Decoctionconventional treatmenttype 2 diabetes mellitusdyslipidemia

钟钻仪、张慧芬、阳婉容

展开 >

东莞市中医院内分泌科,广东 东莞 523000

疏肝清脂方 常规治疗 2型糖尿病 脂代谢异常

广东省中医药局科研项目

20213020

2024

中成药
国家食品药品监督管理局,信息中心中成药信息站,上海中药行业协会

中成药

CSTPCD北大核心
影响因子:1.217
ISSN:1001-1528
年,卷(期):2024.46(9)
  • 17